Stock Market Today Dow Futures Edge Higher as Oil Prices Slide Micron Leads Tech Rally Amgen Releases First Quarter 2026 Earnings Report Key Highlights SP 500 Flat as Consumer Shares Rally Energy Slumps Cornings Q1 Performance Gains Traction on Robust Results Vedanta and MCX Among Top 10 Stocks With Highest Retail Shareholding Jump in Q4 AGCO Q1 2026 Earnings Stellar EPS Surprise of 1075 Despite Revenue Gaps and Stock Dip THFF Q1 2026 Earnings Shares Slip Despite Narrow EPS Beat AnheuserBusch Inbev BUD Q1 2026 Earnings EPS Beats Estimates by 815 Amid Volume Recovery MLAB Q1 2026 Earnings Significant EPS Beat Driven by Strong Operational Performance GOOGL Q1 2026 Earnings EPS Misses Amid Accelerated AI Investments Seer Inc SEER Edges Higher as Biotech Stock Tests Key Resistance Lumen Technologies LUMN Slips 156 as Stock Tests Key Support Zone LiqTech International LIQT Surges 8 as Shares Test Key Resistance at 205 Expensify EXFY Edges Higher Key Levels to Watch as Stock Tests Resistance Barrett Business Services Inc BBSI Slips Over 2 as Stock Tests Key Support Zone Stem Inc STEM Slips 3 as Shares Test Key Support Zone Barclays Reports 18 Profit Jump Upgrades Income Outlook Global Ship Lease Q1 2026 Earnings Earnings Beat Estimates Amidst Challenging Market Analyst Report Released for Williams Companies WMB Amid Natural Gas Infrastructure Focus SCYX Q1 2026 Earnings EPS Misses Estimates as No Revenue Reported Stock Rises 491 COLB Q1 2026 Earnings Earnings Beat Masked by Flat Revenue Picture ULH Q1 2026 Earnings Significant EPS Miss Amid Challenging Operating Environment CTRI Q1 2026 Earnings EPS Beats Estimates by 73 No Revenue Data Disclosed KMPR Q1 2026 Earnings Severe EPS Miss Pressures Shares as Investor Confidence Wavers CHPT Q1 2026 Earnings EPS Surprise of 4756 Highlights Cost Discipline Amidst Market Skepticism Interlink Electronics Q3 2025 Earnings NarrowerThanExpected Loss but Stock Declines Autodesk Q1 2026 Earnings EPS Beat Masks Tepid Revenue Signals PRLD Q1 2026 Earnings NarrowerthanExpected Loss Surprises Positively Eli Lillys NextGeneration Obesity Drug Retatrutide Clears Key Trial OXLCN Q4 2025 Earnings Preferred Stock Reports Slight EPS Miss Amid Steady Portfolio Performance Artius II Acquisition Rights AACBR Hold Steady at 025 as Traders Watch Key Levels